Janna A Hol

6PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersFoetal development and medicineNeonatologyCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 01, 2022
Prevalence of (Epi)genetic Predisposing Factors in a 5-Year Unselected National Wilms Tumor Cohort: A Comprehensive Clinical and Genomic Characterization.

Janna A Hol, Roland P Kuiper, Freerk van Dijk

|Feb 10, 2021
TRIM28 variants and Wilms' tumour predisposition.

Janna A Hol, Illja J Diets, Ronald R de Krijger

|Nov 04, 2020
Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience.

Janna A Hol, Marjolijn C J Jongmans, Hélène Sudour-Bonnange

|Dec 04, 2019
Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.

J A Hol, M C J Jongmans, A S Littooij

|Aug 20, 2019
Prognostic significance of age in 5631 patients with Wilms tumour prospectively registered in International Society of Paediatric Oncology (SIOP) 93-01 and 2001.

J A Hol, M I Lopez-Yurda, H Van Tinteren

|Oct 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study Group.

Janna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf

Pageof 1

Frequent Collaborators

2 joint publications

Gema L Ramírez-Villar

2 joint publications

Norbert Graf

1 joint publications

H Van Tinteren

1 joint publications

Annelies M C Mavinkurve-Groothuis